The Boston Globe reports Wednesday, July 13, that women who have vaginal surgery to fix pelvic organ prolapse may suffer more risk than benefit. Quoting the Food and Drug Administration, the article reports patients and surgeons should consider other options.
Natick-based Boston Scientific Corp. along with several other companies will be present September 8 and 9th to meet with an expert panel convened by the FDA to determine whether to ban the mesh altogether.
With more than 100,000 women undergoing surgery every year with plastic mesh to treat a common problem, pelvic organ prolapse, the article quotes the FDA saying most can be successfully treated without mesh.
Here is the rest of the article.